PMC:7402624 / 1321-1814 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"36","span":{"begin":81,"end":89},"obj":"Species"},{"id":"42","span":{"begin":72,"end":80},"obj":"Disease"},{"id":"43","span":{"begin":101,"end":136},"obj":"Disease"},{"id":"44","span":{"begin":138,"end":142},"obj":"Disease"},{"id":"45","span":{"begin":163,"end":181},"obj":"Disease"},{"id":"46","span":{"begin":192,"end":220},"obj":"Disease"},{"id":"47","span":{"begin":343,"end":351},"obj":"Disease"}],"attributes":[{"id":"A36","pred":"tao:has_database_id","subj":"36","obj":"Tax:9606"},{"id":"A42","pred":"tao:has_database_id","subj":"42","obj":"MESH:C000657245"},{"id":"A43","pred":"tao:has_database_id","subj":"43","obj":"MESH:D012128"},{"id":"A44","pred":"tao:has_database_id","subj":"44","obj":"MESH:D012128"},{"id":"A45","pred":"tao:has_database_id","subj":"45","obj":"MESH:D012140"},{"id":"A47","pred":"tao:has_database_id","subj":"47","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"ilation. The case fatality rate can be as high as ~10% (1). Some severe COVID-19 patients display an acute respiratory distress syndrome (ARDS), reflecting severe respiratory damage. In acute respiratory viral infections, pathology can be mediated by the virus directly, by an overaggressive immune response, or both (2–4). However, in severe COVID-19 disease, the characteristics of, and role for the immune response, as well as how these responses relate to clinical disease features, remain"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T12","span":{"begin":72,"end":80},"obj":"Disease"},{"id":"T13","span":{"begin":101,"end":136},"obj":"Disease"},{"id":"T14","span":{"begin":107,"end":136},"obj":"Disease"},{"id":"T15","span":{"begin":138,"end":142},"obj":"Disease"},{"id":"T16","span":{"begin":204,"end":220},"obj":"Disease"},{"id":"T17","span":{"begin":343,"end":351},"obj":"Disease"}],"attributes":[{"id":"A12","pred":"mondo_id","subj":"T12","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A13","pred":"mondo_id","subj":"T13","obj":"http://purl.obolibrary.org/obo/MONDO_0006502"},{"id":"A14","pred":"mondo_id","subj":"T14","obj":"http://purl.obolibrary.org/obo/MONDO_0009971"},{"id":"A15","pred":"mondo_id","subj":"T15","obj":"http://purl.obolibrary.org/obo/MONDO_0006502"},{"id":"A16","pred":"mondo_id","subj":"T16","obj":"http://purl.obolibrary.org/obo/MONDO_0005108"},{"id":"A17","pred":"mondo_id","subj":"T17","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"ilation. The case fatality rate can be as high as ~10% (1). Some severe COVID-19 patients display an acute respiratory distress syndrome (ARDS), reflecting severe respiratory damage. In acute respiratory viral infections, pathology can be mediated by the virus directly, by an overaggressive immune response, or both (2–4). However, in severe COVID-19 disease, the characteristics of, and role for the immune response, as well as how these responses relate to clinical disease features, remain"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T14","span":{"begin":255,"end":260},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_10239"}],"text":"ilation. The case fatality rate can be as high as ~10% (1). Some severe COVID-19 patients display an acute respiratory distress syndrome (ARDS), reflecting severe respiratory damage. In acute respiratory viral infections, pathology can be mediated by the virus directly, by an overaggressive immune response, or both (2–4). However, in severe COVID-19 disease, the characteristics of, and role for the immune response, as well as how these responses relate to clinical disease features, remain"}

{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T6","span":{"begin":204,"end":220},"obj":"http://purl.obolibrary.org/obo/GO_0016032"},{"id":"T7","span":{"begin":292,"end":307},"obj":"http://purl.obolibrary.org/obo/GO_0006955"},{"id":"T8","span":{"begin":402,"end":417},"obj":"http://purl.obolibrary.org/obo/GO_0006955"}],"text":"ilation. The case fatality rate can be as high as ~10% (1). Some severe COVID-19 patients display an acute respiratory distress syndrome (ARDS), reflecting severe respiratory damage. In acute respiratory viral infections, pathology can be mediated by the virus directly, by an overaggressive immune response, or both (2–4). However, in severe COVID-19 disease, the characteristics of, and role for the immune response, as well as how these responses relate to clinical disease features, remain"}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T1","span":{"begin":107,"end":127},"obj":"Phenotype"}],"attributes":[{"id":"A1","pred":"hp_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/HP_0002098"}],"text":"ilation. The case fatality rate can be as high as ~10% (1). Some severe COVID-19 patients display an acute respiratory distress syndrome (ARDS), reflecting severe respiratory damage. In acute respiratory viral infections, pathology can be mediated by the virus directly, by an overaggressive immune response, or both (2–4). However, in severe COVID-19 disease, the characteristics of, and role for the immune response, as well as how these responses relate to clinical disease features, remain"}

{"project":"LitCovid-sentences","denotations":[{"id":"T13","span":{"begin":9,"end":59},"obj":"Sentence"},{"id":"T14","span":{"begin":60,"end":182},"obj":"Sentence"},{"id":"T15","span":{"begin":183,"end":323},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"ilation. The case fatality rate can be as high as ~10% (1). Some severe COVID-19 patients display an acute respiratory distress syndrome (ARDS), reflecting severe respiratory damage. In acute respiratory viral infections, pathology can be mediated by the virus directly, by an overaggressive immune response, or both (2–4). However, in severe COVID-19 disease, the characteristics of, and role for the immune response, as well as how these responses relate to clinical disease features, remain"}